gemcitabine has been researched along with Nephrotic Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hinoshita, F; Katagiri, D | 1 |
| Hagiwara, M; Hara, M; Hirayasu, K; Kojima, T; Nishiyama, H; Usui, J; Yamagata, K; Yokoyama, C; Yoshino, T | 1 |
2 other study(ies) available for gemcitabine and Nephrotic Syndrome
| Article | Year |
|---|---|
Gemcitabine-induced thrombotic microangiopathy with nephrotic syndrome.
Topics: Acute Kidney Injury; Aftercare; Antimetabolites, Antineoplastic; Conservative Treatment; Deoxycytidine; Female; Gemcitabine; Humans; Kidney; Middle Aged; Nephrotic Syndrome; Thrombotic Microangiopathies; Treatment Outcome | 2018 |
The Detection of Urinary Podocytes from Drug-Induced Glomerular Thrombotic Microangiopathy in Advanced Cancer Patients.
Topics: Acute Kidney Injury; Aged; Antineoplastic Agents; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasms; Nephrotic Syndrome; Podocytes; Predictive Value of Tests; Protein Kinase Inhibitors; Retrospective Studies; Thrombotic Microangiopathies; Time Factors; Urinalysis; Urine | 2016 |